CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

ak105

mAbexperimental

Clinical trial activity

22 trials · 16 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
19
Phase 3
4
Phase 4
0

Earliest trial started Dec 22, 2017 (NCT03352531)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2018

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05718778N/AMar 20, 2023Henan Medical University
NCT05563480Phase 2Oct 27, 2022Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT05683704Phase 2Sep 1, 2022Tianjin Medical University
NCT05244993Phase 2Jul 31, 2022Anshan Tumor Hospital, Dalian Medical University, Fukuang General Hospital of Liaoning health industry group, Huludao central hospital
NCT05333276Phase 1May 31, 2022Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT05313906Phase 2May 7, 2022Henan Medical University, Henan Provincal People's Hospital, Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT05068206Phase 2Oct 8, 2021Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT05033587Phase 2Sep 30, 2021Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd, Nanjing University
NCT04736810Phase 2Feb 28, 2021Akeso Pharmaceuticals, Inc., Chinese Academy of Medical Sciences
NCT04736823Phase 2Feb 1, 2021Akeso Pharmaceuticals, Inc., Sun Yat-Sen University
NCT04385550Phase 3May 20, 2020Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT04344158Phase 3May 1, 2020Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT04291248Phase 2Mar 31, 2020Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT04207463Phase 2Jan 1, 2020Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT04203719Phase 2Jan 1, 2020Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
NCT04172506Phase 1/Phase 2 (Phase 2)Aug 28, 2019Akeso Pharmaceuticals, Inc., Zhejiang University
NCT03866967Phase 2Mar 1, 2019Akeso Pharmaceuticals, Inc., Fudan University
NCT03866993Phase 3Dec 20, 2018Akeso Pharmaceuticals, Inc., Jiao Tong University, People's Liberation Army of China
NCT03866980Phase 3Nov 27, 2018Akeso Pharmaceuticals, Inc., Jiao Tong University, People's Liberation Army of China
NCT04172571Phase 2Nov 22, 2018Akeso Pharmaceuticals, Inc., People's Liberation Army of China
Showing 20 of 22 trials
Page 1 / 2

Organizations

Research & Development (16)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,LtdFor profit10832020
Akeso Pharmaceuticals, Inc.For profit9932017
People's Liberation Army of ChinaGovernment3022018
Henan Medical UniversityAcademic/Hospital2222022
Jiao Tong UniversityAcademic/Hospital2012018
Anshan Tumor HospitalAcademic/Hospital1012022
Chinese Academy of Medical SciencesAcademic/Hospital1012021
Dalian Medical UniversityAcademic/Hospital1112022
Fudan UniversityAcademic/Hospital1012019
Fukuang General Hospital of Liaoning health industry groupAcademic/Hospital1012022
Henan Provincal People's HospitalAcademic/Hospital1012022
Huludao central hospitalAcademic/Hospital1012022
Nanjing UniversityAcademic/Hospital1112021
Sun Yat-Sen UniversityAcademic/Hospital1012021
Tianjin Medical UniversityAcademic/Hospital1112022
Zhejiang UniversityAcademic/Hospital1012019
16 organizations
Page 1 / 1